Market Snapshot

Market Overview

The Molecular Biology Reagents Market size is expected to reach USD 10.2 billion and is projected to reach a CAGR of 14.3% from 2023-2030.

Reagents are essential to the success of PCR reactions, nucleic acid separation, and restriction enzyme digestion experiments. Working with appropriate and dependable materials like buffers, water, enzymes, and chemicals is essential since molecular biology reagents may make or break your experiment or sample preparation.

Water that is suitable for amplification processes and processing RNA includes PCR-Grade and RNase-Free water, respectively. DNA and nucleotides can be purchased alone or as a component of genomic and protein packages. We provide chelating agents EDTA and EGTA, which are often used and designed for a variety of DNA, protein, and cell culture tasks. We provide a wide range of enzymes for genomic research, including but not restricted to polymerases, topoisomerases, and methylases.

The Molecular Biology Reagents market size has grown significantly in recent years. However, due to the outbreak of the COVID-19 pandemic, the market experienced a sharp decline in 2020. Governments from all around the world are collaborating with pharmaceutical and biotech businesses to combat the COVID-19 epidemic, from fostering the creation of vaccinations to preparing for issues with the distribution of medical supplies. The market for molecular biology enzymes, kits, and reagents is also anticipated to be significantly impacted by COVID-19 due to the disruption of the raw material supply chain in several nations. In addition, as makers of these items have slowed down their manufacturing as a result of the pandemic, the market growth of molecular biology reagents is dropping.

 

Delvens Industry Expert's Standpoint

The study of genomics and molecular biology has undergone a complete transformation thanks to the ever-expanding uses of sequencing technologies and the creation of enormous data sets. NGS's introduction made it possible to sequence DNA in a quick and inexpensive manner. Together with NGS, third-generation sequencing technology is revitalizing genome sequencing and solving long-standing issues with de novo genome assembly, haplotype phasing, and structural variation analysis. Companies are continually developing and releasing new sequencing reagents in response to the increased demand for sequencing technologies on a worldwide scale which is further anticipating the growth of the molecular biology reagent market.

Market Portfolio

Key Findings

• The Application segment is further segmented into PCR, Sequencing, Cloning, Epigenetics, Restriction Digestion, Synthetic Biology, and Other Applications. The other application segment is anticipated to dominate the market during the forecast period and sequencing held the second largest share. This development can be linked to the growing use of sequencing-based medical therapies and their application in cancer. For instance, Pacific Biosciences and Berry Genomics worked together in January 2022 to introduce their long-read sequencing technology to the Chinese clinical market. In the near future, it is projected that activities like these would propel the industry.
   
• The End User segment is further segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Centers, and other end users. The pharma and biotech segment held the largest share. This is because molecular biology tools that streamline workflow, such as PCR, sequencing, and genotyping, are widely accepted. The pharma and biotech businesses' use of these items during the development of drug candidates, customized medicine, or diagnostics facilitates product improvements, which in turn boosts sales. The market will be driven in the next years by enterprises' extensive use of molecular technologies during R&D and clinical trials.

• The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. The North American region is expected to be the largest region in the Molecular Biology Reagents market during the forecast period. Due to the existence of bio-clusters in countries like India and China and a rise in the outsourcing of research activities to these nations, Asia-Pacific is anticipated to have attractive development prospects in the molecular biology reagents market.

 

Regional Analysis

North America to Dominate the Market

• The North American region is expected to be the largest region in the Molecular Biology Reagents market during the forecast period.
   
• Due to the existence of bio-clusters in countries like India and China and a rise in the outsourcing of research activities to these nations, Asia-Pacific is anticipated to have attractive development prospects in the molecular biology reagents market.

 

Competitive Landscape

• Thermo Fisher Scientific, Inc.
• Merck KGaA
• Promega Corporation
• New England Biolabs
• Illumina, Inc.
• Takara Bio, Inc.
• Qiagen N.V.
• Agilent Technologies, Inc.
• F. Hoffmann-La Roche Ltd.
• Bio Basic Inc.
• Jena Bioscience GmbH
• Molecular Biology Resources, Inc.
• Bio-Rad Laboratories, Inc.
• Zymo Research Corporation
• Integrated DNA Technologies, Inc.